RSCM
Rock Springs Capital Management Portfolio holdings
AUM
$1.6B
1-Year Return
25.98%
This Quarter Return
-8.24%
1 Year Return
+25.98%
3 Year Return
+194.74%
5 Year Return
+336.76%
10 Year Return
+2,199.29%
AUM
$3.44B
AUM Growth
-$537M
(-14%)
Cap. Flow
+$63.8M
Cap. Flow
% of AUM
1.86%
Top 10 Holdings %
Top 10 Hldgs %
35%
Holding
142
New
7
Increased
68
Reduced
12
Closed
10
Top Buys
| 1 |
Align Technology
ALGN
|
$32.7M |
| 2 |
Humana
HUM
|
$27M |
| 3 |
Health Care Select Sector SPDR Fund
XLV
|
$25.6M |
| 4 |
Penumbra
PEN
|
$24.5M |
| 5 |
TPTX
Turning Point Therapeutics, Inc. Common Stock
TPTX
|
$20.5M |
Top Sells
| 1 |
HCA Healthcare
HCA
|
$94M |
| 2 |
Encompass Health
EHC
|
$35.7M |
| 3 |
iRhythm Technologies
IRTC
|
$17.9M |
| 4 |
XENT
Intersect ENT, Inc
XENT
|
$15.4M |
| 5 |
Rigel Pharmaceuticals
RIGL
|
$14.7M |
Sector Composition
| 1 | Healthcare | 96.7% |
| 2 | Consumer Staples | 0.96% |
| 3 | Industrials | 0.47% |
| 4 | Financials | 0.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AMRN
126
Amarin Corp
AMRN
$307M
| – | – |
-220,985
| Closed | -$14.5M |
|
127
Athira Pharma
ATHA
$15M
| – | – |
-552,252
| Closed | -$7.46M |
|
128
Cullinan Oncology
CGEM
$408M
| – | – |
-652,578
| Closed | -$6.83M |
|
|
129
Encompass Health
EHC
$12.5B
| – | – |
-631,643
| Closed | -$35.7M |
|
|
130
Rigel Pharmaceuticals
RIGL
$713M
| – | – |
-492,149
| Closed | -$14.7M |
|
131
Shattuck Labs
STTK
$60.4M
| – | – |
-313,499
| Closed | -$1.34M |
|
|
LENZ
132
LENZ Therapeutics
LENZ
$1.12B
| – | – |
-255,822
| Closed | -$9.13M |
|
|
PSTX
133
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| – | – |
-289,754
| Closed | -$1.3M |
|
|
XENT
134
DELISTED
Intersect ENT, Inc
XENT
| – | – |
-550,000
| Closed | -$15.4M |
|
|
135
HCA Healthcare
HCA
$97.1B
| – | – |
-375,000
| Closed | -$94M |
|